Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAP Block vs Ilioinguinal Nerve Block for Inguinal Herniorraphy Pain
NCT02375100Completed
- Sponsor
- Bozyaka Training and Research Hospital
- Start
- Feb 2015
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of bupivacaine hydrochloride 0.75% injection in postoperative pain (3 arms), sponsored by Bozyaka Training and Research Hospital. Primary endpoint: Pain Assessment with Verbal Descriptor Scale at 1 month. Started Feb 2015; status: completed.
02
Drugs
bupivacaine hydrochloride 0.75% injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02375100.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02375100.